MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address various unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure...
142 insider purchases on record · latest filing 2026-03-10.
Insiders have also filed 208 sale transactions at MNKD.